0740-0017

Seraseq™ HIV-1 Drug Resistance and Tropism Reference Material

/globalassets/images/product-pages/hiv_dr_products.jpg
  • Size

    3 × 1.0 mL

  • List Price

    Contact Us

  • Unit

    EA

  • Inventory Status

    In Stock

Description

Seraseq HIV-1 Drug Resistance and Tropism Reference Material, created with AccuPlex™ recombinant viral technology, evaluates the detection of 47 mutations across protease (PRO), reverse transcriptase (RT), and integrase (INT) regions. The reference material also contains envelope sequences indicative of either CCR5 or CXCR4 co-receptor usage.

Seraseq HIV-1 Drug Resistance and Tropism Reference Material can be utilized to develop, evaluate, monitor or troubleshoot HIV-1 next-generation sequencing (NGS) assays that identify drug resistance mutations or assess the gene sequence for the GP120 variant loops to determine tropism. Key product features include the following:

  • Assesses 47 mutations across protease (PRO), reverse transcriptase (RT), and integrase (INT) regions of HIV-1 virus
  • Contains envelope sequences indicative of either CCR5 or CXCR4 co-receptor usage to monitor tropism determination
  • Includes three separate mixtures to assess a range of minor variants (target mutation frequencies of 20%, 5% and 1%)
  • Manufactured in cGMP compliant, ISO 9001 and ISO 13485 certified facilities

Seraseq HIV-1 Drug Resistance and Tropism Reference Material - List of Mutations

 

 

 

 

 

 

 

 

 

 

 

 

 





The Seraseq HIV-1 Drug Resistance and Tropism Reference Material is intended for use by diagnostics manufacturers, researchers, and clinical laboratories to develop, evaluate, monitor or troubleshoot NGS HIV-1 drug resistance assays. 

For research use only. Not for use in diagnostic procedures.